“With the advancement of medical science, diagnosing liver diseases has become easier and more accurate than ever before. Among the modern techniques that have revolutionized the diagnosis of liver fibrosis is liver elastography. This non-invasive method provides a fast and precise way to measure the stiffness of liver tissue, helping doctors assess liver health and determine the degree of fibrosis without the need for complex or painful procedures. In this article from Daleely Medical, we will explore how liver elastography works, its benefits, and how it can be a safe and effective solution for the early detection of liver diseases.”
Liver elastography is a medical test used to measure the stiffness of liver tissue to diagnose liver fibrosis (tissue hardening) or other pathological changes in the liver. This can be done using various techniques such as ultrasound, magnetic resonance imaging (MRI), or high-frequency shear wave imaging.
Elastography works by sending sound or magnetic waves through the liver tissue to measure the speed at which these waves travel. The stiffer the tissue (as in liver fibrosis), the faster the waves move. This allows doctors to determine the degree of liver fibrosis accurately.
Yes, liver elastography is generally very safe, as it is non-invasive and does not involve painful procedures. The technique does not use harmful radiation, except for MRI-based elastography, which may require contrast agents that are generally considered safe.
Yes, in some cases it is recommended to fast for 3–4 hours before the test, especially for MRI-based elastography (MRE), which may require fasting for 4–6 hours. For FibroScan or Shear Wave Elastography (SWE), preparation is minimal, though it is better to avoid heavy meals or carbonated drinks before the test for more accurate results.
Liver elastography is completely painless. It uses a device similar to an ultrasound or a special machine to send sound or magnetic waves. Patients may feel slight pressure on the abdomen, but the procedure itself does not cause pain.
Typically, liver elastography takes about 5 to 10 minutes, depending on the type of test and the patient’s condition. FibroScan is usually faster, while MRI-based elastography (MRE) may take longer.
Liver elastography is primarily used to detect liver fibrosis caused by conditions such as chronic hepatitis or fatty liver disease. However, it does not provide a definitive diagnosis for certain conditions like liver tumors or viral hepatitis, which may require additional tests.
Results are usually reported in kilopascals (kPa) or as wave speed, helping assess the degree of fibrosis:
Less than 6 kPa: No fibrosis or mild fibrosis
6 – 9.5 kPa: Moderate fibrosis
More than 9.5 kPa: Severe fibrosis
These results help doctors make appropriate treatment decisions based on the degree of liver fibrosis.
If results indicate mild to moderate fibrosis, regular monitoring is usually recommended to ensure fibrosis does not progress. For severe fibrosis, additional interventions or continuous medical follow-up may be required to monitor liver health and guide treatment.
Yes, liver elastography can be performed on patients with conditions like diabetes or high blood pressure. It is important to inform the doctor about all current health conditions or medications, as factors such as obesity or pregnancy may affect the results.
Liver elastography is a non-invasive and safe alternative to traditional liver biopsy. While a biopsy requires taking a liver tissue sample with a needle for laboratory testing, elastography allows doctors to obtain accurate information about the liver without any surgical intervention, making it faster and safer.
Elastography is a diagnostic tool that helps determine the extent of liver fibrosis but does not treat the disease itself. However, it assists in making appropriate treatment decisions, such as adjusting medications, planning therapies, or scheduling regular monitoring.
In most cases, liver elastography does not require contrast dye. However, if the test is performed using Magnetic Resonance Elastography (MRE), a contrast agent may be used to improve imaging accuracy and measure liver tissue stiffness more precisely.
Yes, after the test, you can return to your normal daily activities without any restrictions. Liver elastography is non-invasive and painless, so it does not require a recovery period.
Not always. Liver elastography may not be suitable for some patients, such as:
Pregnant women: MRI-based elastography may be avoided due to potential risks from contrast agents.
Patients with severe skin conditions: Skin problems may affect image quality or tissue detection.
How it works: Uses ultrasound waves to measure the speed of waves traveling through the liver. Stiffer tissue (e.g., fibrotic tissue) transmits waves faster.
Uses: Commonly used to assess liver fibrosis in patients with hepatitis or liver disease.
Advantages:
Non-invasive and safe
Requires no special preparation
Usually performed in outpatient clinics
How it works: A specialized device sends vibrating waves through the liver. The speed of these vibrations is measured to determine fibrosis level.
Uses: Primarily used to evaluate liver fibrosis and monitor its progression or improvement.
Advantages:
Fast and painless
No anesthesia or special preparation needed
High accuracy in detecting various degrees of liver fibrosis
How it works: Uses MRI techniques to measure tissue stiffness. The patient may be injected with a contrast agent, then MRI measures wave speed through the liver tissue.
Uses: Diagnoses and monitors liver fibrosis in specific cases, such as chronic hepatitis.
Advantages:
Highly accurate for detecting liver fibrosis
Provides additional information about other liver diseases, such as fatty liver
Non-invasive, no biopsy required
How it works: Uses high-frequency ultrasound waves to generate small tissue vibrations. Liver stiffness is measured based on vibration speed.
Uses: Mainly for diagnosing liver fibrosis in patients with chronic liver diseases.
Advantages:
Safe and painless
Can be performed during routine ultrasound exams
Provides accurate data without anesthesia
Early detection of liver fibrosis – Enables doctors to intervene early to prevent disease progression to advanced stages like complete cirrhosis or liver failure.
Non-invasive alternative to liver biopsy – Safe and avoids the pain or complications associated with biopsies.
Accurate assessment of fibrosis degree – Helps doctors evaluate disease progression and plan treatment.
Monitoring changes over time – Useful for chronic liver diseases such as viral hepatitis or alcohol-related fibrosis.
Guiding treatment plans – Results help determine whether medications, monitoring, or other therapies are needed.
Detection of other liver diseases – Can detect fatty liver, chronic hepatitis, and other conditions.
Painless tissue analysis – Non-invasive and does not use harmful chemicals.
Utilizes advanced technology – Ultrasound and MRI provide high-precision imaging for accurate diagnosis.
Outpatient-friendly – Easy to perform regularly without hospital admission.
Evaluate treatment response – Helps doctors adjust therapy based on fibrosis changes.
Screening high-risk patients – Effective for patients with viral hepatitis or heavy alcohol use.
No complex preparation required – Suitable for routine monitoring.
Reduces need for other tests – Minimizes reliance on CT scans or biopsies.
Useful in early cancer detection – May detect subtle liver tissue changes for early identification of liver tumors.
Medical history: The doctor reviews the patient’s liver history (chronic hepatitis, fatty liver, alcohol use, medications).
Symptoms: Questions about abdominal pain, jaundice, fatigue, or other liver-related symptoms.
Instructions: Depending on the test type, fasting for a few hours may be required.
SWE, FibroScan, MRE: The patient lies on their back or side, sometimes raising an arm or adjusting position to improve liver imaging.
SWE: Ultrasound probe is moved over the upper right abdomen to measure wave speed.
FibroScan: Probe sends vibrations through the liver; the speed is measured to assess stiffness.
MRE: MRI measures tissue stiffness using waves, possibly with contrast dye for more accurate results.
Fibrosis assessment: Wave or vibration speed is measured. Stiffer tissue indicates more fibrosis.
Numeric results: Results are shown in kPa or wave speed. Fibrosis is classified as:
Stage 0: No fibrosis
Stage 1–2: Mild to moderate fibrosis
Stage 3–4: Severe or advanced fibrosis
Procedure:
Patient lies on the examination bed, sometimes raising the right or left arm for better liver imaging.
Gel is applied to the upper right abdomen for wave transmission.
Ultrasound probe sends waves through liver tissue to measure speed and determine fibrosis level.
Data is converted into kPa values indicating fibrosis degree.
Procedure:
The FibroScan device sends vibrations through the liver.
Wave speed is measured to determine liver stiffness and fibrosis stage.
Procedure:
Initial preparation: The patient lies on their back in a comfortable position.
Device placement: The FibroScan probe is placed on the upper abdomen, with ultrasound gel applied to help transmit the waves.
Performing the test: Vibrating waves are sent through the liver tissue, and the device measures the speed of wave transmission. Stiffer tissue allows waves to travel faster.
Results: The degree of fibrosis is displayed on the FibroScan in kilopascals (kPa).
How it works: Uses MRI techniques to measure tissue stiffness. A contrast agent may be injected to improve accuracy.
Procedure:
Initial preparation: The patient may be asked to fast for several hours before the test.
Patient positioning: The patient lies on the MRI table.
Performing the test: A contrast agent is injected intravenously, and the MRI sends magnetic waves through the body to generate vibrations in the liver tissue.
Results: The speed of wave transmission through liver tissue is analyzed to determine fibrosis level.
How it works: Uses high-frequency ultrasound waves to create small tissue vibrations. Liver stiffness is measured based on the vibration speed.
Procedure:
Initial preparation: No special preparation is required; the test can be performed directly in the clinic.
Gel application: Ultrasound gel is applied to the upper abdomen.
Performing the test: The ARFI probe (similar to an ultrasound probe) sends pulses through liver tissue, and vibration speed is measured.
Results: Numeric values indicate fibrosis level based on wave speed.
SWE and FibroScan (TE):
No complex preparation: Usually, no special prep is needed, though the doctor may give instructions.
Food intake: Fasting for 3–4 hours may be recommended, as intestinal movement can affect results.
Avoid carbonated drinks: Avoid soda or caffeinated beverages before the test.
Medication restrictions: Occasionally, certain medications affecting the liver or digestion may be temporarily paused.
MRE:
Fasting: Patients usually fast for 4–6 hours before the test.
Avoid food or fluids: To ensure accurate results.
Medication adjustments: Some medications (e.g., sedatives or CNS-acting drugs) may need to be paused.
Inform the doctor: Notify the doctor about metallic implants (clips, pacemakers) as they may affect MRI results.
ARFI:
Similar preparation to SWE: No special prep needed, but it’s best to avoid eating immediately before the test.
For all types of elastography:
Patient positioning: Lie on back or side with the upper abdomen exposed.
Gel application: Ultrasound gel is applied to the upper abdomen for better wave transmission.
Test duration: Usually 5–10 minutes.
After MRE (if contrast is used):
Observation: The patient may remain under brief monitoring for allergic reactions.
Return to daily activities: Normal activities can be resumed; report side effects like nausea or headache.
After ARFI:
Return to daily life: Non-invasive and painless, so no rest period is needed.
How it works: Measures speed of ultrasound waves through liver tissue; stiffer tissue indicates higher wave speed.
Results interpretation (kPa):
0–6 kPa: No fibrosis or very early fibrosis (mild).
6–7.5 kPa: Mild to moderate fibrosis.
7.5–9.5 kPa: Moderate to severe fibrosis.
>9.5 kPa: Advanced fibrosis or cirrhosis (may have complications like liver failure).
Meaning:
Low (<6 kPa): Healthy liver or very early fibrosis.
Medium (6–9.5 kPa): Fibrosis requiring monitoring.
High (>9.5 kPa): Severe fibrosis needing treatment.
How it works: Measures vibration speed through liver tissue.
Results interpretation (kPa):
<5.5 kPa: No fibrosis or mild.
5.5–7 kPa: Mild to moderate fibrosis.
7–10 kPa: Moderate fibrosis.
>10 kPa: Severe or advanced fibrosis.
Meaning:
Low: No or early-stage fibrosis.
Medium: Mild to moderate fibrosis.
High: Severe fibrosis, may need urgent treatment.
How it works: Measures tissue stiffness after contrast injection.
Results interpretation (kPa):
0–2.5 kPa: No or mild fibrosis.
2.5–4.5 kPa: Mild to moderate fibrosis.
4.5–6 kPa: Moderate to severe fibrosis.
>6 kPa: Very advanced fibrosis.
Meaning:
Low (<2.5 kPa): Healthy liver.
Medium (2.5–4.5 kPa): Mild to moderate fibrosis.
High (>4.5 kPa): Severe fibrosis, may require urgent treatment.
How it works: Uses high-frequency waves to measure liver tissue vibration speed.
Results interpretation (m/s):
<1.2 m/s: No fibrosis or mild.
1.2–1.4 m/s: Mild to moderate fibrosis.
>1.4 m/s: Severe or advanced fibrosis.
Meaning:
Low (<1.2 m/s): No significant fibrosis.
Medium (1.2–1.4 m/s): Mild to moderate fibrosis.
High (>1.4 m/s): Severe fibrosis, may require intervention.